Bank of Montreal’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,397
| Closed | -$180K | – | 3525 |
|
|
2024
Q4 | $180K | Buy |
10,397
+25
| +0.2% | +$482 | ﹤0.01% | 2795 |
|
|
2024
Q3 | $189K | Buy |
+10,372
| New | +$208K | ﹤0.01% | 3049 |
|
|
2022
Q2 | – | Sell |
-17,404
| Closed | -$560K | – | 4126 |
|
|
2022
Q1 | $560K | Sell |
17,404
-3,808
| -18% | -$107K | ﹤0.01% | 2752 |
|
|
2021
Q4 | $491K | Sell |
21,212
-1,509
| -7% | -$39.4K | ﹤0.01% | 2401 |
|
|
2021
Q3 | $623K | Buy |
22,721
+6,122
| +37% | +$186K | ﹤0.01% | 2752 |
|
|
2021
Q2 | $764K | Buy |
16,599
+2,415
| +17% | +$86.6K | ﹤0.01% | 2632 |
|
|
2021
Q1 | $398K | Buy |
14,184
+6,537
| +85% | +$223K | ﹤0.01% | 2776 |
|
|
2020
Q4 | $243K | Sell |
7,647
-8,367
| -52% | -$171K | ﹤0.01% | 3123 |
|
|
2020
Q3 | $254K | Sell |
16,014
-408
| -2% | -$8.55K | ﹤0.01% | 2628 |
|
|
2020
Q2 | $330K | Buy |
16,422
+5,748
| +54% | +$103K | ﹤0.01% | 2475 |
|
|
2020
Q1 | $103K | Sell |
10,674
-388,676
| -97% | -$10.9M | ﹤0.01% | 2585 |
|
|
2019
Q4 | $15M | Buy |
399,350
+66,980
| +20% | +$3.01M | 0.01% | 784 |
|
|
2019
Q3 | $15.5M | Buy |
332,370
+315,253
| +1,842% | +$14.7M | 0.01% | 705 |
|
|
2019
Q2 | $895K | Sell |
17,117
-3,304
| -16% | -$194K | ﹤0.01% | 2126 |
|
|
2019
Q1 | $1.41M | Sell |
20,421
-4,705
| -19% | -$315K | ﹤0.01% | 1869 |
|
|
2018
Q4 | $1.5M | Sell |
25,126
-374
| -1% | -$32.3K | ﹤0.01% | 1675 |
|
|
2018
Q3 | $2.95M | Sell |
25,500
-19,562
| -43% | -$2.21M | ﹤0.01% | 1457 |
|
|
2018
Q2 | $5.69M | Buy |
45,062
+17,129
| +61% | +$2.08M | ﹤0.01% | 1105 |
|
|
2018
Q1 | $3.02M | Sell |
27,933
-711
| -2% | -$78.7K | ﹤0.01% | 1378 |
|
|
2017
Q4 | $3.14M | Sell |
28,644
-34,390
| -55% | -$3.43M | ﹤0.01% | 1363 |
|
|
2017
Q3 | $6.22M | Buy |
63,034
+18,212
| +41% | +$1.77M | 0.01% | 1063 |
|
|
2017
Q2 | $4.54M | Sell |
44,822
-119,098
| -73% | -$12.8M | ﹤0.01% | 1200 |
|
|
2017
Q1 | $18.9M | Buy |
163,920
+134,773
| +462% | +$15.7M | 0.02% | 578 |
|
|
2016
Q4 | $3.26M | Buy |
29,147
+23,723
| +437% | +$2.63M | ﹤0.01% | 1275 |
|
|
2016
Q3 | $609K | Sell |
5,424
-23,717
| -81% | -$2.73M | ﹤0.01% | 2015 |
|
|
2016
Q2 | $3.61M | Sell |
29,141
-2,614
| -8% | -$316K | ﹤0.01% | 1229 |
|
|
2016
Q1 | $3.57M | Buy |
31,755
+1,354
| +4% | +$141K | ﹤0.01% | 1158 |
|
|
2015
Q4 | $3.31M | Buy |
30,401
+24,188
| +389% | +$2.77M | ﹤0.01% | 1166 |
|
|
2015
Q3 | $621K | Buy |
6,213
+2,891
| +87% | +$314K | ﹤0.01% | 1756 |
|
|
2015
Q2 | $379K | Buy |
3,322
+331
| +11% | +$40.1K | ﹤0.01% | 2108 |
|
|
2015
Q1 | $312K | Sell |
2,991
-459
| -13% | -$48.9K | ﹤0.01% | 2173 |
|
|
2014
Q4 | $414K | Buy |
3,450
+849
| +33% | +$112K | ﹤0.01% | 2152 |
|
|
2014
Q3 | $381K | Sell |
2,601
-18,459
| -88% | -$2.85M | ﹤0.01% | 2214 |
|
|
2014
Q2 | $3.52M | Sell |
21,060
-3,966
| -16% | -$706K | ﹤0.01% | 1217 |
|
|
2014
Q1 | $4.97M | Sell |
25,026
-13,407
| -35% | -$2.53M | 0.01% | 943 |
|
|
2013
Q4 | $7.34M | Sell |
38,433
-8,252
| -18% | -$1.54M | 0.01% | 699 |
|
|
2013
Q3 | $7.9M | Sell |
46,685
-7,438
| -14% | -$1.15M | 0.01% | 593 |
|
|
2013
Q2 | $8.21M | Buy |
+54,123
| New | +$7.67M | 0.01% | 557 |
|
Other funds holding CLB
AI
DGI
Bank of Montreal's CLB Position: Q1 2025 in Review
Bank of Montreal sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 10,397 shares — an estimated $180K sold.
Bank of Montreal first reported a position in CLB in Q2 2013 and held it in 38 quarters. The position peaked at $18.9M in Q1 2017. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.
- Bank of Montreal reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
- Bank of Montreal sold 10,397 Core Laboratories shares in Q1 2025, an estimated $180K.
- Bank of Montreal first reported a position in Core Laboratories in Q2 2013 and held it in 38 quarters.
- Bank of Montreal's Core Laboratories position peaked at $18.9M in Q1 2017.
- 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.
Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.